BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 15863305)

  • 1. An epigenetic modifier induces production of (10'S)-verruculide B, an inhibitor of protein tyrosine phosphatases by Phoma sp. nov. LG0217, a fungal endophyte of Parkinsonia microphylla.
    Gubiani JR; Wijeratne EM; Shi T; Araujo AR; Arnold AE; Chapman E; Gunatilaka AA
    Bioorg Med Chem; 2017 Mar; 25(6):1860-1866. PubMed ID: 28202316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics.
    Ala PJ; Gonneville L; Hillman MC; Becker-Pasha M; Wei M; Reid BG; Klabe R; Yue EW; Wayland B; Douty B; Polam P; Wasserman Z; Bower M; Combs AP; Burn TC; Hollis GF; Wynn R
    J Biol Chem; 2006 Oct; 281(43):32784-95. PubMed ID: 16916797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century.
    Campos-Almazán MI; Hernández-Campos A; Castillo R; Sierra-Campos E; Valdez-Solana M; Avitia-Domínguez C; Téllez-Valencia A
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies.
    Sarabia-Sánchez MJ; Trejo-Soto PJ; Velázquez-López JM; Carvente-García C; Castillo R; Hernández-Campos A; Avitia-Domínguez C; Enríquez-Mendiola D; Sierra-Campos E; Valdez-Solana M; Salas-Pacheco JM; Téllez-Valencia A
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29261102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of 5-{4'-[(2-{2-[2-(2-ammonio-eth-oxy)eth-oxy]eth-oxy}eth-yl)carbamo-yl]-4-meth-oxy-[1,1'-biphen-yl]-3-yl}-3-oxo-1,2,5-thia-diazo-lidin-2-ide 1,1-dioxide: a potential inhibitor of the enzyme protein tyrosine phosphatase 1B (PTP1B).
    Ruddraraju KV; Hillebrand R; Barnes CL; Gates KS
    Acta Crystallogr E Crystallogr Commun; 2015 Apr; 71(Pt 4):336-8. PubMed ID: 26029383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand efficiency metrics considered harmful.
    Kenny PW; Leitão A; Montanari CA
    J Comput Aided Mol Des; 2014 Jul; 28(7):699-710. PubMed ID: 24899110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR Study on a Series of Protein Tyrosine Phosphatase 1B Inhibitors.
    Mehta RS; Prajapati HR; Thakkar DV; Brahmkshatriya PS
    Int J Biomed Sci; 2008 Dec; 4(4):266-72. PubMed ID: 23675100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.
    Leone M; Barile E; Vazquez J; Mei A; Guiney D; Dahl R; Pellecchia M
    Chem Biol Drug Des; 2010 Jul; 76(1):10-6. PubMed ID: 20456369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of compound libraries for fragment screening.
    Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
    J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting PTPs with small molecule inhibitors in cancer treatment.
    Jiang ZX; Zhang ZY
    Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.
    Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
    Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
    Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
    Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.